Back Braun, K, von Voss, P, Gotfredsen, CF, et al (1 Jan 2007) 'Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-iv inhibitor, vildagliptin, does not', Diabetes , 56/1, 815
Less common but possible side effects include mild headache, fatigue, or changes in appetite timing throughout the day
21,22 Clinical trials examining the efficacy of GLP-1 receptor agonists in treating alcohol use are ongoing, and the results of these trials will further inform clinical practice
In addition, the rise of direct-to-consumer channels, digital health platforms, and personalized nutrition plans is making these products more accessible
Article Outline Explore Weight Loss Treatments Compound Semaglutide vs Ozempic: Which Is Better for Weight Loss in 2026
This history is invaluable when you need to justify the medical necessity of specific treatments to your insurance provider